All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Lupus Nephritis: A Different Disease in European Patients?

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10313550" target="_blank" >RIV/00216208:11110/15:10313550 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/15:10313550

  • Result on the web

    <a href="http://www.karger.com/Article/Pdf/438844" target="_blank" >http://www.karger.com/Article/Pdf/438844</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1159/000438844" target="_blank" >10.1159/000438844</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Lupus Nephritis: A Different Disease in European Patients?

  • Original language description

    Background: Lupus nephritis (LN) is still associated with significant mortality and substantial risk of progression to endstage renal failure. Its outcome is related to the class and severity of LN and response to treatment, and it is poorer in patientswith renal relapses. Ethnicity has a relatively welldefined impact on the outcome of the patients and their response to treatment and must always be taken into consideration in treatment decisions. Summary: In this article, we provide a review of the impact of ethnicity on the prevalence of systemic lupus erythematosus (SLE), the proportion of patients with SLE developing LN, outcomes of SLE and LN and response of LN to treatment. In European patients, the prevalence of SLE and the proportion of SLE patients with LN are lower and the outcome of LN is better than in nonwhite populations. European patients may respond better to some modes of treatment [e.g. cyclophosphamide (CYC) or rituximab] and may be less frequently refractory to trea

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FE - Other fields of internal medicine

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Kidney Diseases

  • ISSN

    2296-9381

  • e-ISSN

  • Volume of the periodical

    1

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    9

  • Pages from-to

    110-118

  • UT code for WoS article

  • EID of the result in the Scopus database